Healthcare provider profile · identity verified

Steven Long, DO

Family Practice · ALTOONA, WI · NPI 1154784833

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	111
Amlodipine Besylate	Amlodipine Besylate	296	76
Lisinopril	Lisinopril	266	70
Metoprolol Succinate	Metoprolol Succinate	218	58
Levothyroxine Sodium	Levothyroxine Sodium	198	45
Losartan Potassium	Losartan Potassium	197	59
Omeprazole	Omeprazole	188	48
Tamsulosin Hcl	Tamsulosin Hcl	143	38
Simvastatin	Simvastatin	112	31
Allopurinol	Allopurinol	104	24
Metformin Hcl Er	Metformin Hcl	102	26
Rosuvastatin Calcium	Rosuvastatin Calcium	97	31
Furosemide	Furosemide	92	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	25
Montelukast Sodium	Montelukast Sodium	89	26
Warfarin Sodium	Warfarin Sodium	85	19
Metformin Hcl	Metformin Hcl	81	21
Hydrochlorothiazide	Hydrochlorothiazide	79	24
Albuterol Sulfate Hfa	Albuterol Sulfate	70	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	13
Duloxetine Hcl	Duloxetine Hcl	69	13
Pantoprazole Sodium	Pantoprazole Sodium	69	16
Xarelto	Rivaroxaban	69	14
Eliquis	Apixaban	67	18
Gabapentin	Gabapentin	67	18
Trazodone Hcl	Trazodone Hcl	64	19
Clopidogrel	Clopidogrel Bisulfate	62	21
Glipizide Er	Glipizide	61	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	12
Potassium Chloride	Potassium Chloride	58	17
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	55	17
Ezetimibe	Ezetimibe	51	suppressed
Ozempic	Semaglutide	49	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	31
Atenolol	Atenolol	47	14
Tramadol Hcl	Tramadol Hcl	47	15
Doxycycline Monohydrate	Doxycycline Monohydrate	46	23
Trulicity	Dulaglutide	46	suppressed
Sertraline Hcl	Sertraline Hcl	45	suppressed
Terazosin Hcl	Terazosin Hcl	45	11
Jardiance	Empagliflozin	43	suppressed
Chlorthalidone	Chlorthalidone	42	11
Prednisone	Prednisone	41	21
Meloxicam	Meloxicam	40	suppressed
Propranolol Hcl Er	Propranolol Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Prazosin Hcl	Prazosin Hcl	32	suppressed
Famotidine	Famotidine	31	suppressed
Finasteride	Finasteride	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	14
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Fluconazole	Fluconazole	23	suppressed
Metronidazole	Metronidazole	23	16
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Azithromycin	Azithromycin	22	16
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Amoxicillin	Amoxicillin	20	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	17
Carvedilol	Carvedilol	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Naproxen	Naproxen	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Alprazolam	Alprazolam	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Lotemax	Loteprednol Etabonate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error